Mito-LND
Product Specifications
UNSPSC Description
Mito-LND (Mito-Lonidamine) is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation (OXPHOS). Mito-LND inhibits mitochondrial bioenergetics, stimulates the formation of reactive oxygen species, and induces autophagic cell death in lung cancer cells[1].
Target Antigen
Autophagy; Mitochondrial Metabolism; Oxidative Phosphorylation; Reactive Oxygen Species
Type
Reference compound
Related Pathways
Autophagy;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mito-lnd.html
Smiles
O=C(NCCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C4=NN(CC5=CC=C(Cl)C=C5Cl)C6=C4C=CC=C6.[Br-]
Molecular Weight
801.62
References & Citations
[1]Gang Cheng, et al. Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis. Nat Commun. 2019 May 17;10(1):2205.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-134832/Mito-LND-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-134832/Mito-LND-SDS-MedChemExpress.pdf
CAS Number
2361564-49-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1334556-01 0.02 mg (E-Coli)
Recombinant Caenorhabditis elegans Uncharacterized protein AH9.3 (AH9.3)
Ask
View Details MBS1334556-02 0.1 mg (E-Coli)
Recombinant Caenorhabditis elegans Uncharacterized protein AH9.3 (AH9.3)
Ask
View Details MBS1334556-03 0.02 mg (Yeast)
Recombinant Caenorhabditis elegans Uncharacterized protein AH9.3 (AH9.3)
Ask
View Details MBS1334556-04 0.1 mg (Yeast)
Recombinant Caenorhabditis elegans Uncharacterized protein AH9.3 (AH9.3)
Ask
View Details